US sinks another $2.1 billion into a potential vaccine

LONDON — Pharma giants GlaxoSmithKline, and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. GlaxoSmithKline's  global vaccines research and development center is in Rockville. Sanofi US is headquartered in New Jersey. The United States will pay ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.